Page last updated: 2024-10-30

lorazepam and Deficiency Disease, Ornithine Carbamoyltransferase

lorazepam has been researched along with Deficiency Disease, Ornithine Carbamoyltransferase in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaspari, R1
Arcangeli, A1
Mensi, S1
Wismayer, DS1
Tartaglione, T1
Antuzzi, D1
Conti, G1
Proietti, R1

Other Studies

1 other study available for lorazepam and Deficiency Disease, Ornithine Carbamoyltransferase

ArticleYear
Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma.
    Annals of emergency medicine, 2003, Volume: 41, Issue:1

    Topics: Adult; Age Factors; Anticonvulsants; Brain; Citrulline; Coma; Diagnosis, Differential; Electroenceph

2003